The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro
Crossref DOI link: https://doi.org/10.1007/s40268-017-0204-x
Published Online: 2017-08-21
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khalil, Ashraf
Jameson, Mark J.
Funding for this research was provided by:
Cancer Center, UVa, Head and Neck
License valid from 2017-08-21